Comerica Bank’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $949K | Buy |
43,983
+883
| +2% | +$19K | ﹤0.01% | 1561 |
|
|
2025
Q1 | $716K | Buy |
43,100
+42,215
| +4,770% | +$701K | ﹤0.01% | 1674 |
|
|
2024
Q4 | $16.2K | Buy |
885
+169
| +24% | +$3.1K | ﹤0.01% | 3081 |
|
|
2024
Q3 | $11K | Buy |
716
+199
| +38% | +$3.06K | ﹤0.01% | 3166 |
|
|
2024
Q2 | $8.4K | Sell |
517
-427
| -45% | -$6.94K | ﹤0.01% | 3200 |
|
|
2024
Q1 | $17.5K | Sell |
944
-41,353
| -98% | -$765K | ﹤0.01% | 3063 |
|
|
2023
Q4 | $1.32M | Buy |
42,297
+41,861
| +9,601% | +$1.31M | 0.01% | 1387 |
|
|
2023
Q3 | $9.09K | Buy |
+436
| New | +$9.09K | ﹤0.01% | 3225 |
|
|
2020
Q2 | – | Sell |
-4,027
| Closed | -$205K | – | 2270 |
|
|
2020
Q1 | $205K | Buy |
+4,027
| New | +$205K | ﹤0.01% | 2078 |
|
|
2018
Q4 | – | Sell |
-46,269
| Closed | -$1.02M | – | 2266 |
|
|
2018
Q3 | $1.02M | Buy |
+46,269
| New | +$1.02M | 0.01% | 1585 |
|